PREDOMOS study, impact of a social intervention program for socially isolated elderly cancer patients: study protocol for a randomized controlled trial

Elodie Crétel-Durand, Emilie Nouguerède, Hervé Le Caer, Frédérique Rousseau, Frédérique Retornaz, Olivier Guillem, Anne-Laure Couderc, Laurent Greillier, Emmanuelle Norguet, Maud Cécile, Rabia Boulahssass, Francoise Le Caer, Sandrine Tournier, Chantal Butaud, Pierre Guillet, Sophie Nahon, Laure Poudens, Sylvie Kirscher, Sandrine Loubière, Nadine Diaz, Jean Dhorne, Pascal Auquier, Karine Baumstarck, Elodie Crétel-Durand, Emilie Nouguerède, Hervé Le Caer, Frédérique Rousseau, Frédérique Retornaz, Olivier Guillem, Anne-Laure Couderc, Laurent Greillier, Emmanuelle Norguet, Maud Cécile, Rabia Boulahssass, Francoise Le Caer, Sandrine Tournier, Chantal Butaud, Pierre Guillet, Sophie Nahon, Laure Poudens, Sylvie Kirscher, Sandrine Loubière, Nadine Diaz, Jean Dhorne, Pascal Auquier, Karine Baumstarck

Abstract

Background: Cancer incidence and social isolation increase along with advanced age, and social isolation potentiates the relative risk of death by cancer. Once spotted, social isolation can be averted with the intervention of a multidisciplinary team. Techniques of automation and remote assistance have already demonstrated their positive impact on falls prevention and quality of life (QoL), though little is known about their impact on socially isolated elderly patients supported for cancer. The primary objective of the PREDOMOS study is to evaluate the impact of establishing a Program of Social intervention associated with techniques of Domotic and Remote assistance (PS-DR) on the improvement of QoL of elderly isolated patients, treated for locally advanced or metastatic cancer. The secondary objectives include treatment failure, tolerance, survival, and autonomy.

Methods/design: This trial is a multicenter, prospective, randomized, placebo-controlled, open-label, two-parallel group study. The setting is 10 French oncogeriatric centers. Inclusion criteria are patients aged at least 70 years with a social isolation risk and a histological diagnosis of cancer, locally advanced or metastatic disease. The groups are (1) the control group, receiving usual care; (2) the experimental group, receiving usual care associating with monthly social assistance, domotic, and remote assistance. Participants are randomized in a 1:1 allocation ratio. Evaluation times involve inclusion (randomization) and follow-up (12 months). The primary endpoint is QoL at 3 months (via European Organization for Research and Treatment of Cancer (EORTC) QLQ C30); secondary endpoints are social isolation, time to treatment failure, toxicity, dose response-intensity, survival, autonomy, and QoL at 6 months. For the sample size, 320 individuals are required to obtain 90% power to detect a 10-point difference (standard deviation 25) in QoL score between the two groups (20% loss to follow-up patients expected).

Discussion: The randomized controlled design is the most appropriate design to demonstrate the efficacy of a new experimental strategy (Evidence-Based Medicine Working Group classification). National and international recommendations could be updated based on the findings of this study.

Trial registration: ClinicalTrials.gov, NCT02829762 . Registered on 29 June 2016.

Keywords: Elderly cancer; Oncogeriatrics; Randomized controlled trial; Social intervention program; Techniques for domotic and remote assistance.

Figures

Fig. 1
Fig. 1
Study flow chart

References

    1. Mininstère des Affaires Sociales et de la Santé . Préconisations pour une MObilisation NAtionale contre l’ISolement social des Agés (MONALISA). Paris: La Documentation française. 2013.
    1. Vickers N, Pollock AM. Breast lung and colorectal cancer incidence and survival in South Thames Region, 1987-1992: the effect of social deprivation. J Pub Health Med. 1997;19(3):288–94. doi: 10.1093/oxfordjournals.pubmed.a024632.
    1. De Geest K, Bender D, Ahmed A, Goodheart MJ, Dahmoush L, Zimmerman MB, Penedo FJ, Lucci JA, 3rd, Ganjei-Azar P, Thaker PH, Mendez L, Lubaroff DM, Slavich GM, Cole SW, Sood AK, Lutgendorf SK. Social influences on clinical outcomes of patients with ovarian cancer. J Clin Oncol. 2012;30(23):2885–90. doi: 10.1200/JCO.2011.39.4411.
    1. Chen MH, McCarthy EP, Mendu ML, Koo S, Wilhite TJ, Graham PL, Choueiri TK, Hoffman KE, Martin NE, Hu JC, Nguyen PL, Aizer AA. Marital status and survival in patients with cancer. J Clin Oncol. 2013;31(31):3869–76. doi: 10.1200/JCO.2013.49.6489.
    1. Gidron Y, Peveler R, Moss-Morris R, Nausheen B. Social support and cancer progression: a systematic review. J Psychosom Res. 2009;67(5):403–15. doi: 10.1016/j.jpsychores.2008.12.012.
    1. Savvides P, Koroukian SM, Kahana EF, Deimling GT, Rose JH, Bowman KF, Miller RH, Berger NA. Cancer in the elderly. Trans Am Clin Climatol Assoc. 2006;117:147–56.
    1. Santos B, Hardt J, Monette J, Girre V, Atenafu EG, Springall E, Alibhai SM, Puts MT. An update on a systematic review of the use of geriatric assessment for older adults in oncology. Ann Oncol. 2014;25(2):307–15. doi: 10.1093/annonc/mdt386.
    1. Van Puyvelde K, Mohile S, Wedding U, Basso U, Colloca G, Rostoft S, Overcash J, Wildiers H, Steer C, Kimmick G, Kanesvaran R, Luciani A, Terret C, Hurria A, Kenis C, Audisio R, Extermann M, Decoster L. Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations†. Ann Oncol. 2015;26(2):288–300. doi: 10.1093/annonc/mdu210.
    1. Heeren P, Puts M, Topinkova E, Janssen-Heijnen ML, Extermann M, Falandry C, Artz A, Brain E, Colloca G, Flamaing J, Karnakis T, Kenis C, Audisio RA, Mohile S, Repetto L, Van Leeuwen B, Milisen K, Hurria A, Wildiers H. International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol. 2014;32(24):2595–603. doi: 10.1200/JCO.2013.54.8347.
    1. Rainfray M, Mathoulin-Pélissier S, Mertens C, Delva F, Fonck M, Soubeyran PL, Bellera CA. Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. Ann Oncol. 2012;23(8):2166–72. doi: 10.1093/annonc/mdr587.
    1. Decoster L, Van Puyvelde K, De Grève J, Conings G, Milisen K, Flamaing J, Lobelle JP, Wildiers H, Kenis C. Performance of two geriatric screening tools in older patients with cancer. J Clin Oncol. 2014;32(1):19–26. doi: 10.1200/JCO.2013.51.1345.
    1. Aapro M, Bernabei R, Cohen HJ, Droz JP, Lichtman S, Mor V, Monfardini S, Repetto L, Sørbye L, Topinkova E, Extermann M. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG) Crit Rev Oncol Hematol. 2005;55(3):241–52. doi: 10.1016/j.critrevonc.2005.06.003.
    1. Stuck AE, Silliman RA, Ganz PA, Clough-Gorr KM, Moser A. The eight-item modified Medical Outcomes Study Social Support Survey: psychometric evaluation showed excellent performance. J Clin Epidemiol. 2012;65(10):1107–16. doi: 10.1016/j.jclinepi.2012.04.007.
    1. Lachal F, Cardinaud N, Saulnier I, Bhalla D, Roquejoffre A, Rialle V, Preux PM, Dantoine T, Tchalla AE. Efficacy of simple home-based technologies combined with a monitoring assistive center in decreasing falls in a frail elderly population (results of the Esoppe study) Arch Gerontol Geriatr. 2012;55(3):683–9. doi: 10.1016/j.archger.2012.05.011.
    1. Beynon M, Cartwright M, Rixon L, Doll H, Henderson C, Bardsley M, Steventon A, Knapp M, Rogers A, Bower P, Sanders C, Fitzpatrick R, Hendy J, Newman SP, Hirani SP. The effect of telecare on the quality of life and psychological well-being of elderly recipients of social care over a 12-month period: the Whole Systems Demonstrator cluster randomised trial. Age Ageing. 2014;43(3):334–41. doi: 10.1093/ageing/aft185.
    1. Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, Aaronson NK, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–76. doi: 10.1093/jnci/85.5.365.
    1. Darlington AS, Fitzsimmons D, Fayers P, Arraras JI, Bonnetain F, Brain E, Bredart A, Chie WC, Giesinger J, Hammerlid E, O’Connor SJ, Oerlemans S, Pallis A, Reed M, Singhal N, Vassiliou V, Young T, Johnson C, Wheelwright S. International validation of the EORTC QLQ-ELD14 questionnaire for assessment of health-related quality of life elderly patients with cancer. Br J Cancer. 2013;109(4):852–8. doi: 10.1038/bjc.2013.407.
    1. Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, Verweij J, Eisenhauer EA. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer. 2009;45(2):228–47. doi: 10.1016/j.ejca.2008.10.026.
    1. Valagussa P, Moliterni A, Zambetti M, Brambilla C, Bonadonna G. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up. N Engl J Med. 1995;332(14):901–6. doi: 10.1056/NEJM199504063321401.
    1. Syme SL, Berkman LF. Social networks, host resistance, and mortality: a nine-year follow-up study of Alameda County residents. Am J Epidemiol. 1979;109(2):186–204. doi: 10.1093/oxfordjournals.aje.a112674.
    1. Kaplan GA, Knudsen L, Cohen R, Guralnik J, Seeman TE. Social network ties and mortality among the elderly in the Alameda County Study. Am J Epidemiol. 1987;126(4):714–23. doi: 10.1093/oxfordjournals.aje.a114711.
    1. Beekman ATF, Deeg DJH, Stek ML, van Tilburg TG, Visser PJ, Schmand B, Jonker C, Schoevers RA, Holwerda TJ. Increased risk of mortality associated with social isolation in older men: only when feeling lonely? Results from the Amsterdam Study of the Elderly (AMSTEL) Psychol Med. 2012;42(4):843–53. doi: 10.1017/S0033291711001772.
    1. van den Akker M, Buntinxa F, Deckx L. Risk factors for loneliness in patients with cancer: a systematic literature review and meta-analysis. Eur J Oncol Nurs. 2014;18(5):466–77. doi: 10.1016/j.ejon.2014.05.002.
    1. Anouk S, van Deudekom FJ. Functional and cognitive impairment, social environment, frailty and adverse health outcomes in older patients with head and neck cancer, a systematic review. Oral Oncol. 2017;64:27–36. doi: 10.1016/j.oraloncology.2016.11.013.
    1. Gaudier-Diaz MM, Lustberg MB, DeVries AC, Hinzey A. Breast cancer and social environment: getting by with a little help from our friends. Breast Cancer Res. 2016;18(1):54.
    1. Bardsley M, Billings J, Dixon J, Doll H, Beynon M, Hirani S, Cartwright M, Rixon L, Knapp M, Henderson C, Rogers A, Hendy J, Fitzpatrick R, Newman S, Steventon A. Effect of telecare on use of health and social care services: findings from the Whole Systems Demonstrator cluster randomised trial. Age Ageing. 2013;42(4):501–8. doi: 10.1093/ageing/aft008.
    1. Riley J, Chapman C, Dubrey SW, Morris S, Rosen SD, Roughton M, Cowie MR, Dar O. A randomized trial of home telemonitoring in a typical elderly heart failure population in North West London: results of the Home-HF study. Eur J Heart Fail. 2009;11(3):319–25. doi: 10.1093/eurjhf/hfn050.
    1. Pecina JL, Upatising B, Chaudhry R, Shah ND, Van Houten H, Cha S, Croghan I, Naessens JM, Hanson GJ, Takahashi PY. A randomized controlled trial of telemonitoring in older adults with multiple health issues to prevent hospitalizations and emergency department visits. Arch Intern Med. 2012;172(10):773–9.
    1. Roberts C, Callén B, Mort M. Ageing with telecare: care or coercion in austerity? Sociol Health Illn. 2013;35(6):799–812. doi: 10.1111/j.1467-9566.2012.01530.x.
    1. Roberts C, Pols J, Domenech M, Moser I, Mort M. EFORTT investigators. Ethical implications of home telecare for older people: a framework derived from a multisited participative study. Health Expect. 2015;18(3):438–49. doi: 10.1111/hex.12109.
    1. Cortesi E, Roila F. Quality of life as a primary end point in oncology. Ann Oncol. 2001;12(Suppl 3):S3–6. doi: 10.1093/annonc/12.suppl_3.S3.
    1. Sprangers MA, Schwartz CE. An introduction to quality of life assessment in oncology: the value of measuring patient-reported outcomes. Am J Manag Care. 2002;8(18):S550–9.
    1. Pientka L, Höffken K, Wedding U. Quality-of-life in elderly patients with cancer: a short review. Eur J Cancer. 2007;43(15):2203–10. doi: 10.1016/j.ejca.2007.06.001.
    1. Perrone F, Di Maio M. Quality of Life in elderly patients with cancer. Health Qual Life Outcomes. 2003;17:1–44.
    1. Fitzsimmons D. What are we trying to measure? Rethinking approaches to health outcome assessment for the older person with cancer. Eur J Cancer Care. 2004;13(5):416–23. doi: 10.1111/j.1365-2354.2004.00548.x.
    1. Gilbert J, Howse F, Young T, Arrarras JI, Brédart A, Hawker S, George S, Aapro M, Johnson CD, Fitzsimmons D. A systematic review of the use and validation of health-related quality of life instruments in older cancer patients. Eur J Cancer. 2009;45(1):19–32. doi: 10.1016/j.ejca.2008.07.036.
    1. Prescott E, Gronbaek M, Koch U, Johansen C, Bergelt C. Social ties and rick for cancer — a prospective cohort study. Acta Oncol. 2009;48:1010–8. doi: 10.1080/02841860903036230.
    1. Vespa A, Lorenzi P, Miccinesi G, Ricciuti M, Cifarelli W, Susi M, Fabrizio T, Ferrari MG, Ottaviani M, Giulietti MV, Merico F, Aieta M, Spatuzzi R. Evaluation of social support, quality of life, and body image in women with breast cancer. Breast Care (Basel) 2016;11(1):28–32. doi: 10.1159/000443493.
    1. Monette J, Girre V, Wolfson C, Monette M, Batist G, Bergman H, Puts MT. Quality of life during the course of cancer treatment in older newly diagnosed patients. Results of a prospective pilot study. Ann Oncol. 2011;22(4):916–23. doi: 10.1093/annonc/mdq446.
    1. Osterlind K, Hallberg IR, Esbensen BA. Quality of life of elderly persons with cancer: a 6-month follow-up. Scand J Caring Sci. 2007;21(2):178–90. doi: 10.1111/j.1471-6712.2007.00454.x.
    1. de Leeuw RJ, Hordijk GJ, Winnubst JA, Derks W. Quality of life in elderly patients with head and neck cancer one year after diagnosis. Head Neck. 2004;26(12):1045–52. doi: 10.1002/hed.20113.
    1. Jooste V, Bonnetain F, Cottet V, Bizollon MH, Bernard MP, Faivre J, Bouvier AM. Adjuvant treatments do not alter the quality of life in elderly patients with colorectal cancer: a population-based study. Cancer. 2008;113(4):879–86. doi: 10.1002/cncr.23629.
    1. McNees P, Powel LL, Su X, Meneses K, Loerzel VW. Quality of life in older women with early-stage breast cancer in the first year of survivorship. Oncol Nurs Forum. 2008;35(6):924–32. doi: 10.1188/08.ONF.924-932.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren